· 2 min read
Classic Study Maps How Retroviral Enzymes Read RNA Versus DNA Templates
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer
· 2 min read
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Based on the PubMed abstract — the full text of this paper was not freely available.
Baltimore and Smoler, publishing in Proceedings of the National Academy of Sciences in 1971, examined how the DNA-making enzyme found inside RNA tumor viruses chooses its templates and starting material.
Working with purified virus particles from two well-known animal viruses, avian myeloblastosis virus and mouse leukemia virus, the researchers tested how each virus's DNA polymerase — an enzyme that builds new DNA strands — behaves when supplied with different synthetic nucleic acid chains. They found that single-stranded RNA chains built from a repeating single letter code (homoribopolymers) worked efficiently as templates, but only once a short matching DNA starter piece, called a primer, was added. The enzyme then built a new DNA strand until it matched the length of the RNA template. The two viruses showed slightly different preferences among the four possible RNA building blocks tested.
By contrast, when the same DNA-building chains (polydeoxyribonucleotides) were offered as templates instead of RNA, the enzyme mostly failed to make any new DNA at all. The authors conclude these viral enzymes need a primer like other DNA polymerases, but are unusual in strongly preferring RNA templates over DNA ones. The study used only synthetic, repetitive nucleic acids in a test-tube system, so it cannot say how the enzyme behaves with natural, complex genetic sequences or inside a living cell.
Our reflection
This 1971 paper sits far upstream of skincare, but it belongs to the foundational chemistry that first defined how polydeoxyribonucleotides behave as molecules — what makes them a template, a primer, or a product of synthesis. Understanding those basic properties, established decades ago, is part of the long scientific lineage that today's PDRN research and formulation work continues to build on.
Source
Baltimore D, Smoler D (1971). Proceedings of the National Academy of Sciences of the United States of America.
Read the paper on PubMedDOI: 10.1073/pnas.68.7.1507Free full text (PMC)
This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.
Related
A 1991 Haemostasis study on how defibrotide, a polydeoxyribonucleotide-derived drug, suppresses monocyte superoxide generation in vitro.
Read more →1989 rat study: defibrotide, a polydeoxyribonucleotide, limited ischemia-reperfusion damage to liver and heart energy metabolism.
Read more →1988 Journal of Bacteriology study on how a yeast polydeoxyribonucleotide ligase repairs bleomycin-induced DNA strand breaks.
Read more →